Atopic dermatitis may not confer clinically meaningful risk of inflammatory bowel disease or renal malignancy

Hannah Y Gantz; Jonathan D Greenzaid; Steven R Feldman

doi:10.1016/j.jaad.2024.05.072

Atopic dermatitis may not confer clinically meaningful risk of inflammatory bowel disease or renal malignancy

J Am Acad Dermatol. 2024 Sep;91(3):586-588. doi: 10.1016/j.jaad.2024.05.072. Epub 2024 Jun 4.

Authors

Hannah Y Gantz¹, Jonathan D Greenzaid², Steven R Feldman³

Affiliations

¹ Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina. Electronic address: gantzhannah@gmail.com.
² Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
³ Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Social Sciences & Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Dermatology, University of Southern Denmark, Odense, Denmark.

PMID: 38844010
DOI: 10.1016/j.jaad.2024.05.072

No abstract available

Keywords: atopic dermatitis; clinical meaning; general dermatology; inflammatory bowel disease; relative risk; renal malignancy; statistical review.

Publication types

Letter

MeSH terms

Adult
Aged
Dermatitis, Atopic* / epidemiology
Female
Humans
Inflammatory Bowel Diseases* / complications
Inflammatory Bowel Diseases* / epidemiology
Kidney Neoplasms* / epidemiology
Male
Middle Aged
Risk Assessment
Risk Factors